中国医药导报
中國醫藥導報
중국의약도보
CHINA MEDICAL HERALD
2014年
27期
39-41
,共3页
韩芳%张伟东%廖晓凌%王拥军
韓芳%張偉東%廖曉凌%王擁軍
한방%장위동%료효릉%왕옹군
肺栓塞%脑卒中%心型脂肪酸结合蛋白%肌钙蛋白I%诊断%预后
肺栓塞%腦卒中%心型脂肪痠結閤蛋白%肌鈣蛋白I%診斷%預後
폐전새%뇌졸중%심형지방산결합단백%기개단백I%진단%예후
Pulmonary embolism%Stroke%Heart-type fatty acid binding protein%Cardiac troponinⅠ%Diagnosis%Prognosis
目的:探讨心型脂肪酸结合蛋白(H-FABP)联合肌钙蛋白Ⅰ(cTnⅠ)对脑卒中继发性肺栓塞患者早期诊断及判断预后的价值。方法选取2011年1月~2014年4月北京市通州区潞河医院收治的150例脑卒中继发性肺栓塞患者(研究组)及单纯脑卒中患者150例(对照组)。检测并比较治疗前两组及研究组治疗前后H-FABP、cTnⅠ水平。结果治疗前研究组H-FABP [(9.52±2.67)μg/L]及cTnⅠ[(0.15±0.09)μg/L]水平明显高于对照组[(3.87±2.96)、(0.05±0.03)μg/L],差异均有统计学意义(P<0.05);治疗后研究组患者血浆H-FABP、cTnⅠ水平分别为(5.51±1.97)、(0.08±0.03)μg/L,较治疗前明显降低,差异均有统计学意义(P<0.05)。结论脑卒中继发性肺栓塞患者血浆H-FABP及cTnⅠ浓度明显升高,两指标联合有助于脑卒中继发性肺栓塞的早期诊断和短期预后情况的评估。
目的:探討心型脂肪痠結閤蛋白(H-FABP)聯閤肌鈣蛋白Ⅰ(cTnⅠ)對腦卒中繼髮性肺栓塞患者早期診斷及判斷預後的價值。方法選取2011年1月~2014年4月北京市通州區潞河醫院收治的150例腦卒中繼髮性肺栓塞患者(研究組)及單純腦卒中患者150例(對照組)。檢測併比較治療前兩組及研究組治療前後H-FABP、cTnⅠ水平。結果治療前研究組H-FABP [(9.52±2.67)μg/L]及cTnⅠ[(0.15±0.09)μg/L]水平明顯高于對照組[(3.87±2.96)、(0.05±0.03)μg/L],差異均有統計學意義(P<0.05);治療後研究組患者血漿H-FABP、cTnⅠ水平分彆為(5.51±1.97)、(0.08±0.03)μg/L,較治療前明顯降低,差異均有統計學意義(P<0.05)。結論腦卒中繼髮性肺栓塞患者血漿H-FABP及cTnⅠ濃度明顯升高,兩指標聯閤有助于腦卒中繼髮性肺栓塞的早期診斷和短期預後情況的評估。
목적:탐토심형지방산결합단백(H-FABP)연합기개단백Ⅰ(cTnⅠ)대뇌졸중계발성폐전새환자조기진단급판단예후적개치。방법선취2011년1월~2014년4월북경시통주구로하의원수치적150례뇌졸중계발성폐전새환자(연구조)급단순뇌졸중환자150례(대조조)。검측병비교치료전량조급연구조치료전후H-FABP、cTnⅠ수평。결과치료전연구조H-FABP [(9.52±2.67)μg/L]급cTnⅠ[(0.15±0.09)μg/L]수평명현고우대조조[(3.87±2.96)、(0.05±0.03)μg/L],차이균유통계학의의(P<0.05);치료후연구조환자혈장H-FABP、cTnⅠ수평분별위(5.51±1.97)、(0.08±0.03)μg/L,교치료전명현강저,차이균유통계학의의(P<0.05)。결론뇌졸중계발성폐전새환자혈장H-FABP급cTnⅠ농도명현승고,량지표연합유조우뇌졸중계발성폐전새적조기진단화단기예후정황적평고。
Objective To investigate the diagnosis and prognostic value of heart-type fatty acid binding protein com-bined cardiac troponin Ⅰ in stroke-associated pulmonary embolism patients. Methods 150 patients with stroke-asso-ciated pulmonary embolism (study group) and 150 patients of stroke without pulmonary embolism (control group) from January 2011 to April 2014 in Luhe Hospital of Tongzhou District in Beijing City were selected in this study. The H-FABP and cardiac troponin Ⅰ of patients in two groups before treatment and those of the study group after treatment were detected and compared. Results The levels of plasma H-FABP and cardiac troponin Ⅰ of patients before treat-ment in study group [(9.52±2.67), (0.15±0.09) μg/L ] were higher than those of the control group [(3.87±2.96), (0.05±0.03) μg/L], the differences were statistically significant (P<0.05).After treatment, the levels of plasma H-FABP and cardiac troponinⅠ in study group [(5.51±1.97), (0.08±0.03) μg/L] were decreased than pretreatment, the differences were statistically significant (P<0.05). Conclusion The level of H-FABP and cardiac troponinⅠ increasing obviously in stroke-associated pulmonary embolism, and the detection of the two indexs can be helpful for the disease diagnosis and the access of short-time prognosis.